ACR GUIDELINES Bundle (free trial)

Juvenile Idiopathic Arthritis - Therapeutic Approaches for Oligoarthritis, Temporomandibular Joint Arthritis and Systemic JIA

American College of Rheumatology GUIDELINES Apps brought to you free of charge courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1512423

Contents of this Issue

Navigation

Page 10 of 13

11 JIA with active TMJ arthritis Incomplete response or intolerance? and/or NO YES Intra-articular glucocorticoids (no preferred agent) Trial of scheduled NSAIDs Continue treatment and monitor DMARD, disease-modifying antirheumatic drug ; LEF, leflunomide; MTX, methotrexate; NSAIDs, non-steroid anti-inflammatories; TMJ, temporomandibular joint

Articles in this issue

Archives of this issue

view archives of ACR GUIDELINES Bundle (free trial) - Juvenile Idiopathic Arthritis - Therapeutic Approaches for Oligoarthritis, Temporomandibular Joint Arthritis and Systemic JIA